AGIOS PHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q1 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Agios Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2014 to Q3 2024.
  • Agios Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 70.2 %.
  • Agios Pharmaceuticals, Inc. annual Return On Equity for 2023 was -38.1 %, a 84.1% decline from 2022.
  • Agios Pharmaceuticals, Inc. annual Return On Equity for 2022 was -20.7 %, a 122% decline from 2021.
  • Agios Pharmaceuticals, Inc. annual Return On Equity for 2021 was 95.7 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 70.2 +92.2 Jul 1, 2024 Sep 30, 2024
Q2 2024 -47.1 -26.8 -133% Apr 1, 2024 Jun 30, 2024
Q1 2024 -41.4 -21.2 -105% Jan 1, 2024 Mar 31, 2024
Q4 2023 -38.1 -17.4 -84.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -22 +9.04 +29.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -20.2 +9.25 +31.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -20.2 +5.72 +22% Jan 1, 2023 Mar 31, 2023
Q4 2022 -20.7 -116 -122% Oct 1, 2022 Dec 31, 2022
Q3 2022 -31.1 -141 -128% Jul 1, 2022 Sep 30, 2022
Q2 2022 -29.5 -159 -123% Apr 1, 2022 Jun 30, 2022
Q1 2022 -26 -196 -115% Jan 1, 2022 Mar 31, 2022
Q4 2021 95.7 +159 Oct 1, 2021 Dec 31, 2021
Q3 2021 110 +168 Jul 1, 2021 Sep 30, 2021
Q2 2021 130 +190 Apr 1, 2021 Jun 30, 2021
Q1 2021 170 +234 Jan 1, 2021 Mar 31, 2021
Q4 2020 -63.5 +9.97 +13.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -57.6 +12.4 +17.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -59.7 +0.18 +0.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -63.9 -15.7 -32.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -73.4 -29.3 -66.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -70.1 -21.6 -44.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -59.9 -8.18 -15.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -48.2 +13.5 +21.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -44.1 +32.5 +42.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -48.5 +12.9 +21.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -51.7 +7.99 +13.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -61.7 -0.32 -0.52% Jan 1, 2018 Mar 31, 2018
Q4 2017 -76.7 -28.8 -60.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -61.4 -8.05 -15.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -59.7 -12 -25.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -61.4 -24.1 -64.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 -47.8 -17.5 -57.6% Oct 1, 2016 Dec 31, 2016
Q3 2016 -53.4 -27.9 -110% Jul 1, 2016 Sep 30, 2016
Q2 2016 -47.7 -31.3 -192% Apr 1, 2016 Jun 30, 2016
Q1 2016 -37.3 -22.6 -154% Jan 1, 2016 Mar 31, 2016
Q4 2015 -30.4 -7.91 -35.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -25.5 -1.72 -7.25% Jul 1, 2015 Sep 30, 2015
Q2 2015 -16.4 +20 +55% Apr 1, 2015 Jun 30, 2015
Q1 2015 -14.7 +43 +74.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -22.4 Oct 1, 2014 Dec 31, 2014
Q3 2014 -23.7 Jul 1, 2014 Sep 30, 2014
Q2 2014 -36.3 Apr 1, 2014 Jun 30, 2014
Q1 2014 -57.6 Jan 1, 2014 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.